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Abstract
The use of recombinant antigens has been shown to improve both the sensitivity and the
standardization of the serological diagnosis of Farmer’s lung disease (FLD). The aim of this
study was to complete the panel of recombinant antigens available for FLD serodiagnosis
with antigens of Lichtheimia corymbifera, known to be involved in FLD. L. corymbifera pro-
teins were thus separated by 2D electrophoresis and subjected to western blotting with sera
from 7 patients with FLD and 9 healthy exposed controls (HEC). FLD-associated immunore-
active proteins were identified by mass spectrometry based on a protein database specifi-
cally created for this study and subsequently produced as recombinant antigens. The ability
of recombinant antigens to discriminate patients with FLD from controls was assessed by
ELISA performed with sera from FLD patients (n = 41) and controls (n = 43) recruited from
five university hospital pneumology departments of France and Switzerland. Forty-one
FLD-associated immunoreactive proteins from L. corymbifera were identified. Six of them
were produced as recombinant antigens. With a sensitivity and specificity of 81.4 and
77.3% respectively, dihydrolipoyl dehydrogenase was the most effective antigen for dis-
criminating FLD patients from HEC. ELISA performed with the putative proteasome subunit
alpha type as an antigen was especially specific (88.6%) and could thus be used for FLD
confirmation. The production of recombinant antigens from L. corymbifera represents an
additional step towards the development of a standardized ELISA kit for FLD diagnosis.
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Introduction
Hypersensitivity pneumonitis (HP) is an inflammatory lung disease that is caused by an exac-
erbated immune response to repeated inhalation of antigens [1]. Farmer’s lung disease (FLD),
one of the most common occupational HP in the world [2], results from the chronic inhalation
of antigens released into the farmer’s environment by microorganisms, especially during the
handling of spoiled hay or straw. The main recognized causative agents of FLD are actinomy-
cetes such as Sacchropolyspora rectivirgula, and molds of various genera including Aspergillus
species and Lichtheimia corymbifera [3–7]. The role in FLD of the mucoraceous mold L. corym-
bifera (formerly Absidia corymbifera) is supported by several studies demonstrating i) high lev-
els of specific precipitins of L. corymbifera in FLD patients’ sera [3,6], ii) FLD relapses due to
high amounts of L. corymbifera in FLD patient-handled hay [8], and iii) a marked inflamma-
tory response of pulmonary epithelial cells exposed to L. corymbifera [9].
Over the past few decades, HP immunodiagnosis has been based on the use of crude frac-
tions of the microorganisms involved in occupational exposure [10,11]. However, the current
use of recombinant antigens improves both the sensitivity and the standardization of serodiag-
nosis [12]. A strategy consisting in using sera from patients with FLD to identify immunogenic
proteins from environmental microorganisms was applied and allowed the selection of immu-
noreactive proteins from S. rectivirgula [13] and Aspergillus species [14]. Recombinant antigens
from these two species were produced and proved to be effective in the serodiagnosis of FLD
by enzyme-linked immunosorbent assay (ELISA). A panel including L. corymbifera recombi-
nant antigens was expected to further improve the diagnostic performance of the ELISA test.
Comparative western blotting (WB) analysis, performed with L. corymbifera protein extract
and sera from patients with FLD and healthy exposed controls (HEC), identified bands specific
to FLD at 27.7, 40.3, 44.0, and 50.5 kDa [15]. Proteins included in these bands might be suitable
candidates.
Testing recombinant antigens issued from three microorganisms is necessary due to the
microbiological evolution of hay stocks over the course of a year. Farmers are successively
exposed, and for variable lengths of time, to the microflora of the field, and to that of both hay
storage and decayed hay. First, thermotolerant fungi (that is Eurotium amstelodami or L. cor-
ymbifera) develop and cause biochemical changes and an increase in temperature which pro-
vide the optimum conditions for S. rectivirgula and other thermophilic actinomyces to grow
[16]. At each step, except under field microflora exposure, cases of farmer’s lung can appear.
Consequently, some cases are sensitive to one, two or three of these microorganisms.
The main objective of the present study was to identify immunoreactive proteins of L. cor-
ymbifera associated to FLD status so as to complete the panel of recombinant antigens useful
for a standardized and sensitive serodiagnosis of the disease.
Materials and Methods
Patients
Patients (n = 41) diagnosed with FLD pulmonary syndrome on the basis of consensus criteria
[17,18] were consecutively recruited from the pneumology departments of five university hos-
pitals in France and Switzerland from 2006 to 2012. Patient characteristics were described in
detail in a previous study [13]. HEC (n = 43) were recruited from the same areas. The protocol
was approved by the local ethics committee (Comité de Protection des Personnes EST-II–
Regional Health Agency of Franche-Comté (Agence Régionale de Santé de Franche-Comté,
France)), and a written informed consent was obtained from each participant (Projet Hospita-
lier de Recherche Clinique “SOPHIA” 2009-A00546-51). Blood samples were taken from each
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individual and centrifuged within 4 hours of sampling. Sera were immediately frozen and
stored at -80°C until use.
Stored sera from 13 patients diagnosed with probable or proven mucormycosis between
2004 and 2013 were also analyzed using ELISA with L. corymbifera recombinant antigens.
Stored sera from immunocompromised patients without invasive fungal infection (n = 8) and
sera from healthy subjects (n = 16) were also tested by the same ELISA test.
Identification of immunoreactive proteins
The immunoproteomic approach previously described for identification of immunoreactive
proteins from S. rectivirgula [13] was used in this study with only a few changes. Protein
extracts from L. corymbifera (reference strain BBCM/IHEM 3809 isolated from FLD-linked
hay) were prepared as previously described [15]. Briefly, the process consisted of the enzymatic
lysis of the fungal cell wall with a recombinant β-1,3-glucanase (Lyticase from Arthrobacter
luteus, Sigma-Aldrich1, St Louis, MO, USA), followed by protein precipitation with trichloro-
acetic acid in presence of deoxycholate and protein purification with the SDS-Page Clean-Up
Kit (GE Healthcare1, Piscataway, USA). A set of sera from FLD patients (n = 7) and from
HEC (n = 9) which detect bands representative of each group with the weakest background sig-
nals was selected from a previous 1D-WB experiment [15]. Protein extracts (25 μg) were sepa-
rated by two dimensional SDS-PAGE on small size gels, and immunoreactive proteins were
detected by WB using the selected sera. Comparing blots allowed us to identify spots specifi-
cally detected with patient sera. A large size gel and membrane were then prepared with 50 and
100 μg of protein extract, respectively, to locate the spots of interest with greater accuracy.
Spots of interest were excised from the large 2D gel colored with colloidal Coomassie blue after
alignment with the large membrane probed with four representative sera from FLD patients.
Corresponding proteins, putative markers of the disease, were then identified by liquid chro-
matography coupled with tandem mass spectrometry (LC-MS/MS) analysis. Sequencing of L.
corymbiferamRNA was performed to create a database for protein identification by mass spec-
trometry, because at the beginning of this study, the L. corymbifera genome had not yet been
sequenced.
L. corymbifera RNA extraction, mRNA sequencing and database
construction
L. corymbifera RNA was extracted from cells grown on DG18 agar medium for one week at
30°C. Fungal cells from 20 plates were then resuspended in 60 ml of sodium phosphate buffer
(10 mM Na3PO4 and 0.15 M NaCl, pH 6). After 10 min of centrifugation at 12,000 x g at 4°C,
pelleted cells were frozen in liquid nitrogen to disrupt the fungal cell wall, and total RNA was
extracted using the RNeasy Mini kit (QIAgen1, Hilden, Germany), according to the manufac-
turer’s instructions.
Shotgun sequencing of normalized mRNA sample was performed by Microsynth (Balgach,
Switzerland) using 454 FLX technology (454 Roche GS FLX, Roche1), and contigs were assem-
bled with the GS De Novo Assembler version 2.5.3 using the default settings for cDNA. This
run generated 269,021 reads with an average length of 323.3 bases, and 11,529 contigs (average
length of 810 bases) were reconstructed. 7,110 were qualified as large contigs (>500 bases).
A single file in FASTA format compiling all amino acid sequences derived from the transla-
tion of these contigs according to the three possible reading frames was used as a database for
protein identification by mass spectrometry.
During the preparation of this manuscript, the L. corymbifera genome (strain FSU 9682,
CBS 429.75, ATCC 46771) was sequenced, and annotated protein sequences were added to the
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National Center for Biotechnology (NCBI) database by Schwartze et al. [19]. A blastp with
ncbi databases was performed to annotate the 41 proteins (potential diagnostic markers) iden-
tified in this study by mass spectrometry based on our database. Thirty-three out of the 41 pre-
dicted amino acid sequences were 98 to 100% identical to the L. corymbifera newly published
protein sequences. The eight remaining sequences aligned with those of Absidia idahoensis var.
thermophila, with identity percentages comprised between 84 and 99%.
Development of recombinant antigens
Open reading frames of proteins of interest, deduced from L. corymbiferamRNA sequencing,
were chemically synthesized, inserted between the NcoI and BamHI restriction sites of the
expression vector pET-11aH6 [20] by the Genecust laboratory (Luxembourg). After cloning in
Escherichia coli strain DH5α, recombinant plasmids were isolated and then inserted into bacte-
rial strain BL21 for protein expression. Recombinant protein production was induced by add-
ing isopropyl β-D-1-thiogalactopyranoside (final concentration 0.1 mM) for 4 hours to mid-
log phase cells cultured in LB medium, and 6 × His-tagged proteins were extracted by affinity
chromatography on Ni-NTA resin (Qiagen1) columns as recommended by the manufacturer.
ELISA tests
Detection of specific IgG in sera was performed by ELISA tests as described by Barrera et al.
[13] using each of the six recombinant antigens produced.
Serum samples from patients with FLD (n = 41) and controls (n = 43), diluted 100 X, were
deposited, in triplicate, in the wells of 96-well plates previously coated with 200 μl of recombi-
nant antigen solution (1 μg/ml). Each plate included a reference sample (pool of sera from two
FLD patients: FLD07 and FLD35) which was used for normalization between plates calculating
ELISA indexes. ELISA tests were performed in three independent experiments. For each exper-
iment, the two closest absorbance (A450 nm) values obtained with each serum were averaged,
and an index corresponding to the ratio between the mean A of the serum sample and the
mean A of the reference sample was calculated. The mean of the three index values obtained in
the three independent experiments was then calculated for each serum sample.
For each recombinant antigen, we assessed the performance of the ELISA tests for FLD
diagnosis by analyzing the receiver operating characteristics (ROC) curve (Stata9). The thresh-
old, which best discriminated patients from controls, was determined from the best percentage
for correct classification, with the best combination of sensitivity and specificity.
Results
Detection of immunoreactive proteins by 2D PAGE andWB with sera
from FLD patients and HEC
L. corymbifera protein extracts were subjected to 2D PAGE on small gels andWB. Sixteen small
membranes were prepared, and probed with the nine selected sera from HEC and the seven
selected sera from FLD patients. All in all, 64 clearly distinct spots were detected on the different
membranes probed with FLD sera (data not shown). All these spots were located and numbered
on each of the membranes. Twenty-three spots were thought to be associated with FLD patients
because i) they were detected with at least three of the seven sera from patients with FLD and ii)
they were detected at least twice more often with FLD sera than with HEC sera.
We then carried out 2D PAGE on two large gels. The first gel was stained with Coomassie
blue. About 200 clearly individualized spots could be seen on the gel (Fig 1A). Proteins from
the second gel were transferred onto a large membrane that was probed with a pool of sera
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from four FLD patients (chosen among the 7 initially selected) which, when combined, allowed
the detection of the 64 FLD spots (Fig 1B). Alignment between the gel and the membrane
enabled the accurate location on the gel of 55 of the 64 spots previously seen using small mem-
branes. Among the 23 spots described as associated with FLD status using small membranes,
21 were visible on the large gel and could be cut for LC-MS/MS analysis (Fig 1). Two spots
(spots 61 and 62) were not visible on the gel.
Forty-one different proteins were identified from the excised spots. The characteristics and
biological functions of these proteins are given in Table 1. Eleven proteins are responsible for
energy production and conversion (LC1, LC3, LC5, LC8, LC10, LC19, LC20, LC22, LC35,
LC36, LC39), eight are involved in carbohydrate transport (LC2, LC9, LC11, LC15, LC18,
LC21, LC34, LC37), eight ensure posttranslational modifications and protein turnover (LC17,
LC25, LC27-LC33), five play a role in amino acid transport and metabolism (LC6, LC7, LC14,
LC24, LC26, LC35), and four are involved in lipid transport and metabolism (LC12, LC16,
LC23, LC40). LC4 function consists of inorganic ion transport and metabolism. LC41 has a sig-
nal transducer activity.
Fig 1. 2D-electrophoresis of L. corymbifera protein extract and western blotting with sera from FLD patients and HEC. (A) Large gel stained with
Coomassie blue. (B) Large membrane probed with a pool of representative sera from FLD patients (FLD02, FLD08, FLD10 and FLD12). (C) Small
membrane probed with one serum representative of HEC (HEC22). Of the 64 immunoreactive spots detected with FLD sera and numbered on the large
blot (B), only a few were recovered on each membrane probed with HEC sera (C). In contrast, 55 of these spots were clearly located on the gel colored
with Coomassie blue (A). All spots defined as associated with FLD patients (spots with numbers written in boldface and underlined) were excised from the
gel for protein identification by mass spectrometry, except spots 61 and 62 which were not accurately located on the gel.
doi:10.1371/journal.pone.0160888.g001
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Table 1. Characteristics of L. corymbifera immunoreactive proteins. Proteins written in bold were produced as recombinant antigens.
Code ncbi accession
number*
Protein identiﬁcation Biological function Spot number on Fig 1 (spectra)§
LC1 CDH58998.1 Fumarate reductase Energy production and conversion 28 (3); 29 (5)
LC2 CDH54616.1 Pyruvate kinase Carbohydrate transport and metabolism 10 (5); 11 (3); 18 (6)
LC3 CDH52287.1 v-type atpase Energy production and conversion 11 (5)
LC4 CDH60495.1 Catalase Inorganic ion transport and metabolism 18 (4)
LC5 CDH55589.1 Dihydrolipoyl dehydrogenase Energy production and conversion 10 (6); 11 (5); 18 (6)
LC6 CDH53460.1 Bleomycin hydrolase Amino acid transport and metabolism 55 (2)
LC7 CDH59771.1 Carboxypeptidase y precursor Amino acid transport and metabolism 55 (18); 56 (9); 57 (15)
LC8 CDH59240.1 Aldehyde dehydrogenase Energy production and conversion 10 (3); 11 (3); 35 (2)
LC9 CDH56669.1 Enolase Carbohydrate transport and metabolism 11 (2)
LC10 CDH49193.1 Atp synthase f1 beta subunit Energy production and conversion 10 (3); 11 (3); 55 (2)
LC11 CDH58368.1 Carbohydrate esterase family 9 protein Carbohydrate transport and metabolism 10 (2); 11 (2)
LC12 CDH58504.1 Acyl oxidase Lipid transport and metabolism 35 (3); 36 (5); 37 (3); 38 (4)
LC13 CDH55682.1 Probable qcr2-40 kda ubiquinol
cytochrome-creductase core protein 2
General function prediction only 35 (14); 36 (19); 37 (18); 38 (16)
LC14 CDS05524.1 Putative Glutamine synthetase Amino acid transport and metabolism 55 (3); 56 (3); 57 (2)
LC15 CDH55124.1 Alpha-mannosidase Carbohydrate transport and metabolism 36 (3)
LC16 CDS10668.1 Putative Isovaleryl-CoA dehydrogenase,
mitochondrial
Lipid transport and metabolism 36 (2)
LC17 CDH49332.1 Heat shock protein hss1 Posttranslational modiﬁcation, protein
turnover, chaperones
55 (2)
LC18 CDS11245.1 Hypothetical protein LRAMOSA03508
(putative adenosine kinase)
Carbohydrate transport and metabolism 35 (3); 36 (2)
LC19 CDH52624.1 Atp synthase subunit alpha Energy production and conversion 10 (3); 11 (5); 18 (6); 19 (8); 21 (9);
24 (13); 28 (12); 29 (11); 30 (9); 31
(13); 32(6)
LC20 CDH57483.1 Malate dehydrogenase Energy production and conversion 35 (3); 49 (4); 50 (2); 51 (5); 55 (3);
57 (3)
LC21 CDH53020.1 Transaldolase Carbohydrate transport and metabolism 49 (2)
LC22 CDS13358.1 Hypothetical protein LRAMOSA05536
(putative ATP synthase subunit gamma)
Energy production and conversion 55 (3); 56 (4); 57 (2)
LC23 CDH51333.1 Enoyl-hydratase Lipid transport and metabolism 55 (6); 56 (3); 57 (2)
LC24 CDH59027.1 Saccharopine dehydrogenase Amino acid transport and metabolism 10 (2); 11 (3)
LC25 CDS10670.1 Hypothetical protein LRAMOSA11156
(putative serine protease)
Posttranslational modiﬁcation, protein
turnover, chaperones
49 (2); 51 (2)
LC26 CDH60921.1 Glutamate dehydrogenase (nad ()) Amino acid transport and metabolism 10 (2); 11 (2)
LC27 CDH60383.1 Serine protease Posttranslational modiﬁcation, protein
turnover, chaperones
35 (3); 36 (2); 49 (3); 50 (3); 51 (2)
LC28 CDS13594.1 Putative proteasome subunit alpha type Posttranslational modiﬁcation, protein
turnover, chaperones
49 (2); 55 (5); 56 (3); 57 (2)
LC29 CDH55408.1 Proteasome subunit alpha type-6 Posttranslational modiﬁcation, protein
turnover, chaperones
57 (2)
LC30 CDH57557.1 20s proteasome subunit Posttranslational modiﬁcation, protein
turnover, chaperones
55 (2)
LC31 CDH54172.1 N-terminal nucleophile aminohydrolase Posttranslational modiﬁcation, protein
turnover, chaperones
55 (2)
LC32 CDH59238.1 Peptidase s28 Posttranslational modiﬁcation, protein
turnover, chaperones
11 (2)
LC33 CDS02842.1 Putative Proteasome subunit beta type Posttranslational modiﬁcation, protein
turnover, chaperones
55 (2)
(Continued)
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Selection of recombinant antigens
As shown in Table 1, a single spot could contain several proteins (for example, spot 18 that
contains LC2, LC4, LC5, LC19 and LC37), and several spots could contain the same proteins
(for example, this was the case for spots 35, 36, 37, 38 that all contained LC12 and LC13). The
latter spots thus contain isoforms of the same proteins. Spots aligned on the 2D gel (spots with
similar molecular masses (MM)) are concerned (spots 10 and 11; spots 19, 21, 24, 28 and 29;
spots 30–32; spots 35–38; spots 49–51; spots 55–57) (Table 1). Spot 18 was an isolated spot.
For each series of isoforms cited above or for spot 18, we decided to produce as recombinant
antigens for the diagnostic test, the protein identified with the highest number of spectra in
LC-MS/MS (Table 1; last column). When the corresponding cDNA sequence was incomplete
or presented too many uncertain bases, the protein with the second or the third highest num-
ber of spectra was selected. Six of the 41 proteins were thus produced in a recombinant form in
the E. coli expression system: pyruvate kinase (LC2), dihydrolipoyl dehydrogenase (LC5), acyl
oxydase (LC12), ATP synthase subunit alpha (LC19), malate dehydrogenase (LC20) and puta-
tive proteasome subunit alpha type (LC28).
ELISA tests
ELISA tests were performed using each of the six recombinant antigens and sera from 41 FLD
patients and 43 HEC. Diagnostic performances of the tests were assessed by ROC curve analy-
ses. With AUC below 0.80, four of the six recombinant antigens (LC2, LC12, LC19, and LC20)
were not considered effective enough for FLD serodiagnosis. Among the two remaining recom-
binant antigens, LC5 was the most effective for discriminating FLD patients from HEC, with
an AUC of 0.83 and a sensitivity and a specificity of 81.4 and 77.3%, respectively (Fig 2). ELISA
using LC28 as an antigen also showed an AUC above 0.80, with a specificity of 88.6%, but the
sensitivity was only 65.1%. Combining both recombinant antigens did not improve the diag-
nostic performance of the test (Fig 2).
Table 1. (Continued)
Code ncbi accession
number*
Protein identiﬁcation Biological function Spot number on Fig 1 (spectra)§
LC34 CDH53462.1 Hypothetical protein RO3G_06829
(Predicted peptidoglycan/xylan/chitin
deacetylase)
Carbohydrate transport and metabolism,
Cell wall/membrane/envelope biogenesis
35 (2)
LC35 CDH50476.1 Methylmalonate-semialdehyde
dehydrogenase
Energy metabolism, Amino acids and
amines
10 (3); 11 (2)
LC36 CDH49687.1 Glutathione-disulﬁde reductase Energy metabolism, Electron transport 19 (2); 21 (3)
LC37 CDH58020.1 Glucose-6-phosphate 1-dehydrogenase Carbohydrate transport and metabolism 18 (2)
LC38 CDS13524.1 Hypothetical protein LRAMOSA05700
(CRAL/TRIO domain-containing protein)
Unknown function 57 (2)
LC39 CDH58972.1 Malate dehydrogenase Energy production and conversion 35 (3); 36 (2); 38 (2)
LC40 CDH56788.1 3-hydroxybutyryl-dehydrogenase Lipid transport and metabolism 51 (2)
LC41 CDH49357.1/
CDH49812.1
Guanine nucleotide binding protein beta
subunit
Signal transducer activity 35 (2); 36 (2); 49 (2); 51 (2); 55 (3);
56 (2); 57 (2)
*Accession numbers are written in italics for Absidia idahoensis var. thermophila proteins. The others are accession numbers of Lichtheimia corymbifera
(strain FSU 9682, CBS 429.75, ATCC 46771) proteins.
§Identiﬁcation number on Fig 1 of the spot from which the protein was identiﬁed (number of fragmentation spectra (MS/MS) that allowed protein
identiﬁcation).
doi:10.1371/journal.pone.0160888.t001
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Table 2 classifies the individuals included in our study into the FLD group or the HEC
group according to results obtained in ELISA with LC5 et LC28 recombinant antigens from L.
corymbifera, the two most efficient recombinant antigens from Aspergillus sp. [14], and the
three from S. rectivirgula [13]. There are several negative results but all subjects, except one
FLD (FLD22) and one HEC (HEC15), were correctly classified with at least one recombinant
antigen. Theoretical characteristics of the ELISA test were determined for all combinations of 2
to 7 recombinant antigens (Table 3). The best results were obtained with two combinations of
three recombinant antigens, the first one including LC5 from L. corymbifera, Glucose-6-Phos-
phate isomerase from Aspergillus and SR6 from S. rectivirgula and the second one, LC5, SR6
and SR17. When the ELISA result was positive with at least two of the three recombinant anti-
gens from both combinations, the subject was classified as an FLD patient. Conversely, when
the ELISA result was negative with at least two of the recombinant antigens, the subject was
classified as an HEC. Based on these two rules, 83.7% of the subjects were correctly classified.
Sensitivity and specificity were both superior to 80% (Table 3).
None of the six recombinant antigens was able to discriminate patients with mucormycosis
from immunocompromised patients without invasive fungal infection and from healthy sub-
jects in ELISA (data not shown).
Discussion
Using an optimal immunoproteomic approach, we produced six recombinant antigens specific
to L. corymbifera, two of which, LC5 (dihydrolipoyl dehydrogenase) and LC28 (putative pro-
teasome subunit alpha type), improved FLD diagnosis. In particular, LC5 was the most effec-
tive recombinant antigen for discriminating FLD patients from HEC by ELISA with very good
sensitivity (81.4%) and specificity (77.3%). ELISA performed with the LC28 antigen was partic-
ularly specific (88.6%) and could thus be useful as a confirmation test.
Bands at 27.7, 40.3, 44.0, and 50.5 kDa were previously identified as specific to FLD patients
by 1D-WB experiments [15]. Results from 1D- and 2D-WB were compared to determine
whether the recombinant antigens produced in this study could correspond to proteins
Fig 2. Characteristics of the ELISA test for 6 recombinant antigens from L. corymbifera The percentage of individuals correctly classified,
sensitivity, specificity, and area under the curve (AUC) were determined by receiver operating characteristics curve analysis. The diagnostic
performance of the test performed with a combination of two recombinant antigens (LC5 and LC28) was assessed using a scoring system, as
previously described by Barrera et al. [13].
doi:10.1371/journal.pone.0160888.g002
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Table 2. Correct classification* of patients with FLD and healthy exposed controls (HEC) according
to ELISA results obtained with each recombinant antigen from L. corymbifera, Aspergillus sp. and S.
rectivirgula. G6Pi, Glucose-6-Phosphate isomerase; GLPV, Glu/Leu/Phe/Val dehydrogenase.
Correctly classiﬁed
L. corymbifera
antigens
Aspergillus antigens S. rectivirgula antigens
LC5 LC28 G6Pi GLPV SR1FA SR6 SR17
FLD patients
FLD01 X X X X
FLD02 X X X X X X X
FLD03 X X X X X X X
FLD04 X X X X
FLD05 X X X X X X X
FLD06 X
FLD07 X X X X X
FLD08 X X
FLD09 X X X X
FLD10 X X X X
FLD11 X X X X X X
FLD12 X
FLD13 X X X X X X
FLD14 X X X X X X
FLD15 X X X X X X X
FLD16 X X X X X
FLD17 X X X X X X X
FLD18 X X X X X X X
FLD19 X X X X X X X
FLD20 X X X
FLD21 X X
FLD22
FLD23 X X X X X
FLD24 X X X X X
FLD25 X X X X X X X
FLD26 X X X X X X X
FLD27 X X X
FLD28 X X X X X X X
FLD29 X X X X X
FLD30 X X
FLD31 X X X X X X
FLD32 X X X X
FLD33 X X X X X X X
FLD34 X X
FLD35 X X X X X
FLD36 X X X X X X X
FLD37 X X X
FLD38 X X X X X X
FLD39 X X X X
FLD40 X X X X X
FLD41 X X X X X X X
Healthy exposed controls
(Continued)
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Table 2. (Continued)
Correctly classiﬁed
L. corymbifera
antigens
Aspergillus antigens S. rectivirgula antigens
LC5 LC28 G6Pi GLPV SR1FA SR6 SR17
HEC01 X X X X X X X
HEC03 X X X X
HEC05 X X X X X X
HEC06 X X X X X X X
HEC08 X X X X X X X
HEC09 X X X X X X
HEC10 X X X X X X
HEC11 X X X X X X X
HEC12 X X X X X X X
HEC14 X X X X X X
HEC15
HEC16 X X X
HEC17 X X X X X X X
HEC18 X X X X X X X
HEC19 X X X X X X
HEC20 X X X X X X
HEC21 X X X X X X X
HEC22 X X X X X X
HEC23 X X X X X X
HEC24 X X X X X X X
HEC25 X X X X X X X
HEC26 X X X X X X X
HEC27 X X X X X X X
HEC28 X X X
HEC29 X X X X X X
HEC30 X X X X X X X
HEC31 X X X X X X X
HEC32 X X X X X X
HEC33 X
HEC34 X X X X X X X
HEC35 X X X X
HEC36 X X X X X X X
HEC37 X X X X X
HEC38 X X X X X X
HEC39 X X X X X X
HEC40 X X X X X X X
HEC41 X X
HEC42 X X X X X
HEC43 X
*Correct classiﬁcations are indicated by crosses: for an FLD patient, classiﬁcation was considered as correct
when the ELISA result was positive and for an HEC, when the ELISA result was negative. Classiﬁcations of
HEC02, HEC04, HEC07 and HEC13 are not reported in the table because their sera were not tested in
ELISA performed with Aspergillus antigens.
doi:10.1371/journal.pone.0160888.t002
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Table 3. Theoretical characteristics of the ELISA test for different combinations of recombinant antigens from L. corymbifera, Aspergillus sp. and
S. rectivirgula. Sensitivity, specificity and percentage of individuals correctly classified were determined for all combinations of 2 to 7 recombinant antigens
from the results reported in Table 2. Only the combinations giving a percentage of individuals correctly classified exceeding 75% were reported in this table.
Combinations of recombinant antigens giving the best diagnostic performance were underlined and written in italics.
Antigens Minimum number of antigens allowing correct
classiﬁcation
Sensitivity (%) Speciﬁcity (%) Correctly classiﬁed
(%)
LC5+LC28+G6Pi 2 73.2 82.1 77.6
LC5+LC28+GLPV 2 65.9 84.6 75.2
LC5+LC28+SR1FA 2 70.7 84.6 77.7
LC5+LC28+SR6 2 78.0 84.6 81.3
LC5+LC28+SR17 2 70.7 84.6 77.7
LC5+G6Pi+SR1FA 2 73.2 82.1 77.6
LC5+G6Pi+SR6 2 85.4 82.1 83.7
LC5+G6Pi+SR17 2 75.6 82.1 78.8
LC5+GLPV+SR1FA 2 70.7 82.1 76.4
LC5+GLPV+SR6 2 75.6 82.1 78.8
LC5+GLPV+SR17 2 70.7 82.1 76.4
LC5+SR1FA+SR6 2 78.0 87.2 82.6
LC5+SR1FA+SR17 2 70.7 87.2 79.0
LC5+SR6+SR17 2 85.4 82.1 83.7
LC28+G6Pi+SR1FA 2 70.7 84.6 77.7
LC28+G6Pi+SR6 2 75.6 84.6 80.1
LC28+G6Pi+SR17 2 68.3 84.6 76.5
LC28+GLPV+SR1FA 2 65.9 87.2 76.5
LC28+GLPV+SR6 2 68.3 87.2 77.7
LC28+SR1FA+SR6 2 75.6 87.2 81.4
LC28+SR1FA+SR17 2 65.9 87.2 76.5
LC28+SR6+SR17 2 78.0 82.1 80.1
G6Pi+GLPV+SR6 2 70.7 82.1 76.4
G6Pi+SR1FA+SR6 2 70.7 87.2 79.0
G6Pi+SR1FA+SR17 2 73.2 87.2 80.2
G6Pi+SR6+SR17 2 75.6 82.1 78.8
GLPV+SR1FA+SR6 2 68.3 87.2 77.7
GLPV+SR1FA+SR17 2 70.7 87.2 79.0
GLPV+SR6+SR17 2 80.5 82.1 81.3
SR1FA+SR6+SR17 2 78.0 82.1 80.1
LC5+LC28+SR6+SR17 3 70.7 79.5 75.1
LC5+LC28+G6Pi+GLPV+SR1FA 3 70.7 82.1 76.4
LC5+LC28+G6Pi+GLPV+SR6 3 73.2 82.1 77.6
LC5+LC28+G6Pi+GLPV+SR17 3 68.3 82.1 75.2
LC5+LC28+G6Pi+SR1FA+SR6 3 78.0 84.6 81.3
LC5+LC28+G6Pi+SR1FA+SR17 3 68.3 84.6 76.5
LC5+LC28+G6Pi+SR6+SR17 3 78.0 84.6 81.3
LC5+LC28+GLPV+SR1FA+SR6 3 73.2 84.6 78.9
LC5+LC28+GLPV+SR1FA+SR17 3 68.3 84.6 76.5
LC5+LC28+GLPV+SR6+SR17 3 75.6 84.6 80.1
LC5+LC28+SR1FA+SR6+SR17 3 78.0 87.2 82.6
LC5+G6Pi+GLPV+SR1FA+SR6 3 70.7 82.1 76.4
LC5+G6Pi+GLPV+SR1FA+SR17 3 70.7 82.1 76.4
LC5+G6Pi+GLPV+SR6+SR17 3 78.0 82.1 80.1
(Continued)
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contained within these bands. Three of the six recombinant proteins produced in this study
had MM similar to those of the four bands detected significantly more often with sera from
FLD patients than with sera from HEC in 1D-WB [15]. Indeed, with respective MM of 53.8,
46.5 and 27.4 kDa, LC5, the most effective recombinant antigen in our study, LC12 and LC28,
are likely to correspond to bands of 50.5, 44.0 and 27.7 kDa described as FLD-specific in
1D-WB analysis. LC5, LC12 and LC28 were identified in the current study from spots whose
MM were estimated to be close to 50, 44 and 31 kDa, respectively. Given the discrepancy
observed between the theoretical MM of a protein and its apparent MM on an acrylamide gel
or a blot (2D or 1D), LC2 which has an MM of 58.5 kDa but was identified from spots with an
apparent MM of 50 kDa (spots 10, 11 and 18) could also be related to the 1D-detected band of
50.5 kDa.
We previously identified immunoreactive proteins and produced recombinant antigens
from one other mold (Aspergillus), one actinomycete (S. rectivirgula) and one mycobacterium
(Mycobacterium immunogenum) using the same methodology [13,14,20]. The present study
focused on an organism whose genomic DNA sequence was not initially available. mRNA
from the fungus was thus sequenced, and resulting contigs were translated according to the
three possible reading frames to quickly create a database (including only proteins produced by
the strains used for antigen production) for protein identification by mass spectrometry. This
strategy seems to be effective since 33 out of the 41 immunoreactive proteins identified from
our database aligned well (identities comprised between 98 to 100%) with newly published L.
corymbifera protein sequences [19]. The eight remaining sequences were 84 to 99% identical to
those of Absidia idahoensis var. thermophila. Problems of producing cDNA from mRNA are
often encountered when eukaryotic recombinant proteins have to be produced in a prokaryotic
system. We were able to avoid these problems by chemically synthesizing the open reading
frames of the proteins of interest, thus making it much easier to produce recombinant proteins.
Almost all immunoreactive proteins from L. corymbifera identified in this study are meta-
bolic enzymes (Table 1). As previously reported for S. rectivirgula [13], the presence of
Table 3. (Continued)
Antigens Minimum number of antigens allowing correct
classiﬁcation
Sensitivity (%) Speciﬁcity (%) Correctly classiﬁed
(%)
LC5+G6Pi+SR1FA+SR6+SR17 3 78.0 87.2 82.6
LC5+GLPV+SR1FA+SR6+SR17 3 75.6 87.2 81.4
LC28+G6Pi+GLPV+SR1FA+SR6 3 73.2 84.6 78.9
LC28+G6Pi+GLPV+SR1FA+SR17 3 70.7 84.6 77.7
LC28+G6Pi+GLPV+SR6+SR17 3 73.2 84.6 78.9
LC28+GLPV+SR1FA+SR6+SR17 3 75.6 87.2 81.4
LC28+G6Pi+SR1FA+SR6+SR17 3 73.2 87.2 80.2
G6Pi+GLPV+SR1FA+SR6+SR17 3 73.2 87.2 80.2
LC5+LC28+G6Pi+GLPV+SR1FA
+SR6
4 68.3 82.1 75.2
LC5+LC28+G6Pi+SR1FA+SR6
+SR17
4 68.3 82.1 75.2
LC5+LC28+GLPV+SR1FA+SR6
+SR17
4 68.3 82.1 75.2
LC28+G6Pi+GLPV+SR1FA+SR6
+SR17
4 68.3 82.1 75.2
LC5+G6Pi+GLPV+SR1FA+SR6
+SR17
4 68.3 82.1 75.2
doi:10.1371/journal.pone.0160888.t003
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antibodies directed against L. corymbiferametabolic proteins in patients’ sera, coupled with the
fact that cultures of bronchoalveolar lavage from patients with FLD are generally negative,
strongly suggests that the fungus remains metabolically active for a few hours in the lungs of
FLD patients before being eliminated by the immune system. FLD symptoms generally appear
4 to 8 hours after exposure. This suggests an immune response against a growing microorgan-
ism producing metabolic enzymes after spore germination.
Patients are unequally sensitized to all microorganisms involved in FLD, and it is now a
proven fact that the causative species vary according to agricultural practices and geographical
area [3,4,6]. L corymbifera has been demonstrated to be an important etiologic agent of FLD by
epidemiological and serological arguments [6]. We provide here additional evidence of an
FLD-specific humoral response to some antigenic proteins from L. corymbifera. Involvement
of L. corymbifera in FLD has been described mainly in eastern France and Finland [3,4,6]. For
the most part, the patients included in this study have been living either in eastern France or in
a nearby region of Switzerland. Combining recombinant antigens LC5 and LC28 from L. cor-
ymbifera with recombinant antigens providing the best sensitivity from S. rectivirgula (SR1FA,
SR6 and SR17 [13]) and from Aspergillus (Glucose-6-Phosphate isomerase and Glu/Leu/Phe/
Val dehydrogenase [14]) was likely to improve the performance of the test since some patients
showed negative results in ELISA when antigens from only one or two micro-organisms were
used (Table 2). Patient FLD 22 showed negative results with all the antigens from all three
microorganisms. The serum from this patient could contain antibodies against antigenic pro-
teins that were not identified by the immunoproteomic approach used. Alternatively, FLD22
could be one of the patients that are exposed to microorganisms involved in FLD but do not
develop antibodies (or only a few) against these agents as previously reported by Fenoglio et al.
[21]. Although HEC15 did not present any clinical or radiological signs, he did have positive
ELISA results with all recombinant antigens. With a total of 83.7% of subjects correctly classi-
fied, combinations of recombinant antigens including LC5, Glucose-6-Phosphate isomerase
and SR6 or LC5, SR6 and SR17 proved to be very effective in diagnosing FLD in our study
(Table 3). A prospective study using these combinations in ELISA is currently ongoing in our
laboratory to assess diagnostic performance with patients from different geographical origins.
Moreover, a slot blot analysis will be evaluated using the same combination of recombinant
antigens.
Combining recombinant antigens from three important etiologic agents of FLD (S. rectivir-
gula, Aspergillus and L. corymbifera), we are now about to produce a standardized ELISA kit
that could be used for FLD diagnosis whatever the geographical origin of patients may be. Dif-
ferent panels of recombinant antigens, providing either high sensitivity or good specificity in
ELISA, could be used to produce both a screening test and a confirmation test.
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